Aline Herlopian

Aline Herlopian practices at Yale Medicine in New Haven, Connecticut.

Aline Herlopian's NPI, 1790063899, was assigned on July 25, 2011. Aline Herlopian holds Connecticut license 56303.

Aline Herlopian's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Aline Herlopian's primary practice is Yale Medicine in New Haven, Connecticut. Aline Herlopian is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Aline Herlopian to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Aline Herlopian practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Aline Herlopian's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Aline Herlopian is licensed in Connecticut.

CMS data shows 769 Medicare services from Aline Herlopian across 10 procedure codes in 2024, for 424 Medicare patients. Medicare paid $76,025 for them.

CMS counts 424 Medicare patients who saw Aline Herlopian in 2024. The largest group is under 65, with 137 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 51% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Aline Herlopian's median patient age at 59, with 53% women.

In 2024, Aline Herlopian wrote 4,982 Medicare Part D claims for 375 patients. 69% of them were for generic drugs. CMS names the drug for 4,891 of them, across 48 drugs with 11 or more claims each, at $3,490,636 in total drug cost. In 2023, CMS named 4,745 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Aline Herlopian for performance year 2024, reported as part of a group. Aline Herlopian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Aline Herlopian as offering telehealth.

Dmand AI links 29 papers to Aline Herlopian, published from 2010 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Electroencephalography, Seizures and Epilepsy. Aline Herlopian has published most often in J Clin Neurophysiol. Aline Herlopian's most frequent co-authors are Jonathan J. Halford, MD, Michael Brandon Westover, MD, PhD and Jennifer Kim, MD, PhD.

CMS Open Payments shows 33 general payments to Aline Herlopian from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 62% of the total. UCB, Inc. paid the most, $6,657.